KOD Stock Summary and Trading Ideas (Kodiak Sciences | NASDAQ:KOD)

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Kodiak Sciences trades on the NASDAQ stock market under the symbol KOD.

As of May 13, 2024, KOD stock price climbed to $3.83 with 248,983 million shares trading.

KOD has a beta of 4.48, meaning it tends to be more sensitive to market movements. KOD has a correlation of 0.13 to the broad based SPY ETF.

KOD has a market cap of $201.21 million. This is considered a Small Cap stock.

In the last 3 years, KOD stock traded as high as $131.97 and as low as $1.37.

The top ETF exchange traded funds that KOD belongs to (by Net Assets): VTI, IWM, VXF, DWAS, IWN.

KOD has underperformed the market in the last year with a return of -22.8%, while the SPY ETF gained +27.8%. In the last 3 month period, KOD fell short of the market, returning -28.8%, while SPY returned +4.3%. However, in the most recent 2 weeks KOD has outperformed the stock market by returning +16.8%, while SPY returned +2.5%.

KOD support price is $3.41 and resistance is $3.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KOD stock will trade within this expected range on the day.